Bax expression in mammalian neurons undergoing apoptosis, and in Alzheimer's disease hippocampus

Brain Research

Volumn 750, Issue 1-2, 1997, Pages 223-234

  MacGibbon, G A ^a   Lawlor, P A ^a   Sirimanne, E S ^a   Walton, M R ^a   Connor, B ^a   Young, D ^a   Williams, C ^a   Gluckman, P ^a   Faull, R L M ^a   Hughes, P ^b   Dragunow, M ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; apoptosis; Bax; Bcl 2; brain damage; hypoxic ischaemia; programmed cell death

Indexed keywords

AMYLOID BETA PROTEIN; PROTEIN BAX; TAU PROTEIN;

ADOLESCENT; ADULT; AGED; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN ISCHEMIA; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; NEUROFIBRILLARY TANGLE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BIOLOGICAL MARKERS; CEREBROVASCULAR DISORDERS; FEMALE; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; NEURONS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PYRAMIDAL CELLS; RATS; RATS, WISTAR; REFERENCE VALUES;

EID: 0031044644     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)01351-0     Document Type: Article

References (93)

1. Anderson, A.J., Cummings, B.J. and Cotman, C.W., Increased immunoreactivity for Jun- and Fos-related proteins in Alzheimer's disease: association with pathology, Exp. Neurol., 125 (1994) 286-295.
2. Anderson, A.J., Pike, C.J. and Cotman, C.W., Differential induction of immediate early gene proteins in cultured neurons by β-amyloid (A β): Association of c-Jun with Ab-induced apoptosis, J. Neurochem., 65 (1995) 1487-1498.
3. Beilharz, E.J., Williams, C.E., Dragunow, M., Sirimanne, E.S. and Gluckman, P.D., Mechanisms of delayed cell death following hypoxic-ischemic injury in the immature rat: evidence for apoptosis during selective neuronal loss, Mol. Brain Res., 29 (1995) 1-14.
4. Bissonnette, R.P., Echeverri, F., Mahboubi, A. and Green, D.R., Apoptotic cell death induced by c-myc is inhibited by bcl-2, Nature, 359 (1992) 552-554.
5. Boise, L.H., González-Garcia, M., Postema, C.E., Ding, L., Lindsten, T., Turka, L.A., Mao, X., Nuñez, G. and Thompson, C.B., bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death, Cell, 74 (1993) 597-608.
6. Boyd, J.M., Gallo, G.J., Elangovan, B., Houghton, A.B., Malstrom, S., Avery, B.J., Ebb, R.G., Subramanian, T., Chittenden, T., Lutz, R.J. and Chinnadurai, G., Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins, Oncogene, 11 (1995) 1921-1928.
7. Braak, H. and Braak, E., Neuropathological stageing of Alzheimer-related changes, Acta Neuropathol., 82 (1991) 239-259.
8. Braak, H. and Braak, E., Pathology of Alzheimer's disease. In D.B. Calne (Ed.), Neurodegenerative Diseases, W.B. Saunders Co., Philadelphia, PA, 1994, pp. 585-613.
9. Castrén, E., Ohga, Y., Berzaghi, M.P., Tzimagiorgis, G., Thoenen, H. and Lindholm, D., bcl-2 messenger RNA is localized in neurons of the developing and adult rat brain, Neuroscience, 61 (1994) 165-177.
10. Chen, J., Graham, S.H., Chan, P.H., Lan, J., Zhou, R.L. and Simon, R.P., bcl-2 is expressed in neurons that survive focal ischemia in the rat, NeuroReport, 6 (1995) 394-398.
11. Chittenden, T., Flemington, C., Houghton, A.B., Ebb, R.G., Gallo, G.J., Elangovan, B., Chinnadurai, G. and Lutz, R.J., A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions, EMBO J., 14 (1995) 5589-5596.
12. Chittenden, T., Harrington, E.A., O'Connor, R., Flemington, C., Lutz, R.J., Evan, G.I. and Guild, B.C., Induction of apoptosis by the Bcl-2 homologue Bak, Nature, 374 (1995) 733-736.
13. Choi, S.S., Park, I.-C., Yun, J.W., Sung, Y.C., Hong, S.-I. and Shin, H.-S., A novel Bcl-2 related gene, BfI-1, is overexpressed in stomach cancer and preferentially expressed in bone marrow, Oncogene, 11 (1995) 1693-1698.
14. Cotman, C.W. and Anderson, A.J., A potential role for apoptosis in neurodegeneration and Alzheimer's disease, Mol. Neurobiol., 10 (1995) 19-45.
15. Delacourte, A., General and dramatic glial reaction in Alzheimer brains, Neurology, 40 (1990) 33-37.
16. Dragunow, M., Beilharz, E., Sirimanne, E., Lawlor, P., Williams, C., Bravo, R. and Gluckman, P., Immediate-early gene protein expression in neurons undergoing delayed death, but not necrosis, following hypoxic-ischaemic injury to the young rat brain, Mol. Brain Res., 25 (1994) 19-33.
17. Dragunow, M., de Castro, D. and Faull, R.L.M., Induction of Fos in glia-like cells after focal brain injury but not during wallerian degeneration, Brain Res., 527 (1990) 41-54.
18. Dragunow, M., Faull, R.L.M., Lawlor, P., Beilharz, E., Singleton, K., Walder, L. and Mee, E., In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes, NeuroReport, 6 (1995) 1053-1057.
19. Dragunow, M. and Preston, K., The role of inducible transcription factors in apoptotic nerve cell death, Brain Res. Rev., 21 (1995) 1-28.
20. Dragunow, M., Yamada, N., Bilkey, D.K. and Lawlor, P., Induction of immediate- early gene proteins in dentate granule cells and somatostatin interneurons after hippocampal seizures, Mol. Brain Res., 13 (1992) 119-126.
21. Dragunow, M., Young, D., Hughes, P., MacGibbon, G., Lawlor, P., Singleton, K., Sirimanne, E., Beilharz, E. and Gluckman, P., Is c-Jun involved in nerve cell death following status epilepticus and hypoxic-ischaemic brain injury? Mol. Brain Res., 18 (1993) 347-352.
22. Duffy, P.E., Rapport, M. and Graf, L., Glial fibrillary acidic protein and Alzheimer-type senile dementia, Neurology, 30 (1980) 778-782.
23. Estus, S., Zaks, W.J., Freeman, R.S., Gruda, M., Bravo, R. and Johnson, E.M. Jr., Altered gene expression in neurons during programmed cell death: Identification of c-jun as necessary for neuronal apoptosis, J. Cell Biol., 127 (1994) 1717-1727.
24. Fang, W., Rivard, J.J., Mueller, D.L. and Behrens, T.W., Cloning and molecular characterization of mouse bcl-x in B and T lymphocytes, J. Immunol., 153 (1994) 4388-4398.
25. Farrow, S.N. and Brown, R., New members of the Bcl-2 family and their protein partners, Curr. Opin. Genet. Dev., 6 (1996) 45-49.
26. Farrow, S.N., White, J.H.M., Martinou, I., Raven, T., Pun, K.-T., Grinham, C.J., Martinou, J.-C. and Brown, R., Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19 K, Nature, 374 (1995) 731-733.
27. Frankowski, H., Missotten, M., Fernandez, P.-A., Martinou, I., Michel, P., Sadoul, R. and Martinou, J.-C., Function and expression of the Bcl-x gene in the developing and adult nervous system, NeuroReport, 6 (1995) 1917-1921.
28. Forloni, G., Chiesa, R., Smiroldo, S., Verga, L., Salmona, M., Tagliavini, F. and Angeretti, N., Apoptosis mediated neurotoxicity induced by chronic application of β-amyloid fragment 25-35, NeuroReport, 4 (1993) 532-526.
29. Garcia, I., Martinou, I., Tsujimoto, Y. and Martinou, J.-C., Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene, Science, 258 (1992) 302-304.
30. Gillardon, F., Wickert, H. and Zimmermann, M., Up-regulation of bax and down- regulation of bcl-2 is associated with kainate-induced apoptosis in mouse brain, Neurosci. Lett., 192 (1995) 85-88.
31. Glenner, G.G. and Wong, C.W., Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein, Biochem. Biophys. Res. Commun., 120 (1984) 885-890.
32. Goldstone, S.D. and Lavin, M.F., Prolonged expression of c-jun and associated activity of the transcription factor AP-1, during apoptosis in a human leukaemic cell line, Oncogene, 9 (1994) 2305-2311.
33. González-García, M., García I., Ding, L., O'Shea, S., Boise L.H., Thompson C.B. and Núñez, G., bcl-x is expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death, Proc. Natl. Acad. Sci. USA, 92 (1995) 4304-4308.
34. Gschwind, M. and Huber, G., Apoptotic cell death induced by β-amyloid(1-42) peptide is cell type dependent, J. Neurochem., 65 (1995) 292-300.
35. Gunn, A.J., Dragunow, M., Faull, R.L.M. and Gluckman, P.D., Effects of hypoxia-ischemia and seizures on neuronal and glial-like c-fos protein levels in the infant rat, Brain Res., 531 (1990) 105-116.
36. Haldar, S., Jena, N. and Croce, C.M., Inactivation of Bcl-2 by phosphorylation, Proc. Natl. Acad. Sci. USA, 92 (1995) 4507-4511.
37. Hara, A., Iwai, T., Niwa, M., Uematsu, T., Yoshimi, N., Tanaka, T. and Mori, H., Immunohistochemical detection of Bax and Bcl-2 proteins in gerbil hippocampus following transient forebrain ischemia, Brain Res., 711 (1996) 249-253.
38. Harrigan, M.R., Kunkel, D.D., Nguyen, L.B. and Malouf, A.T., Beta amyloid is neurotoxic in hippocampal slice cultures, Neurobiol. Aging, 16 (1995) 779-789.
39. Hockenbery, D.M., Nuñez, G., Milliman, C., Schreiber, R.D. and Korsmeyer, S.J., Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death, Nature, 348 (1990) 334-336.
40. Hyman, B.T., Van Hoesen, G.W. and Damasio, A.R., Memory-related neural systems in Alzheimer's disease: An anatomic study, Neurology, 40 (1990) 1721-1730.
41. Hyman, B.T., Van Hoesen, G.W., Damasio, A.R. and Barnes, C.L., Alzheimer's disease: cell-specific pathology isolates the hippocampal formation, Science, 225 (1984) 1168-1170.
42. Itagaki, S., McGeer, P.L., Aliyama, H., Zhu, S. and Selkoe, D., Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease, J. Neuroimmunol., 24 (1989) 173-182.
43. Kane, D.J., Örd, T., Anton, R. and Bredesen, D.E., Expression of bcl-2 inhibits necrotic neural cell death, J. Neurosci. Res., 40 (1995) 269-275.
44. Kerr, J.F.R. and Harmon, B.V., Definition and incidence of apoptosis: An historical perspective. In L.D Tomei and P.O. Cope (Eds.), Apoptosis: The Molecular Basis of Cell Death, Cold Spring Harbor Laboratory Press, Plainview, New York, 1991, pp. 5-29.
45. Kerr, J.F.R., Wyllie, A.H. and Currie, A.R., Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics, Br. J. Cancer, 26 (1972) 239-257.
46. Kiefer, M.C., Brauer, M.J., Powers, V.C., Wu, J.J., Umansky, S.R., Tomei, L.D. and Barr, P.J., Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak, Nature, 374 (1995) 736-739.
47. Klempt, N.D., Sirimanne, E., Gunn, A.J., Klempt, M., Singh, K., Williams, C. and Gluckman, P.D., Hypoxia-ischemia induces transforming growth factor b1 mRNA in the infant rat brain, Mol. Brain Res., 13 (1992) 93-101.
48. Korsmeyer, S.J., Bcl-2 initiates a new category of oncogenes: regulators of cell death, Blood, 80 (1992) 879-886.
49. Korsmeyer, S.J., Shutter, J.R., Veis, D.J., Merry, D.E. and Oltvai, Z.N., Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death, Semin. Cancer Biol., 4 (1993) 327-332.
50. Kozopas, K.M., Yang, T., Buchan, H.L., Zhou, P. and Craig, R.W., MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2, Proc. Natl. Acad. Sci. USA, 90 (1993) 3516-3520.
51. Krajewski, S., Krajewska, M., Shabaik, A., Miyashita, T., Gang Wang, H. and Reed, J.C., Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2, Am. J. Pathol., 145 (1994) 1323-1336.
52. Krajewski, S., Mai, J.K., Krajewska, M., Sikorska, M., Mossakowski, M.J. and Reed, J.C., Upregulation of Bax protein levels in neurons following cerebral ischemia, J. Neurosci., 15 (1995) 6364-6376.
53. Krajewski, S., Tanaka, S., Takayama, S., Schibler, M.J., Fenton, W. and Reed, J.C., Investigation of the subcellular distribution of the bcl-2 oncoprotein: Residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes, Cancer Res., 53 (1993) 4701-4714.
54. Lin, E.Y., Orlofsky, A., Berger, M.S. and Prystowsky, M.B., Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2, J. Immunol., 151 (1993) 1979-1988.
55. Linnik, M.D., Zobrist, R.H. and Hatfield, M.D., Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats, Stroke, 24 (1993) 2002-2008.
56. Loo, D.T., Copani, A., Pike, C.J., Whittemore, E.R., Walencewicz, A.J. and Cotman, C.W., Apoptosis is induced by β-amyloid in cultured central nervous system neurons, Proc. Natl. Acad. Sci. USA, 90 (1993) 7951-7955.
57. MacManus, J.P., Buchan, A.M., Hill, I.E., Rasquinha, I. and Preston, E., Global ischemia can cause DNA fragmentation indicative of apoptosis in rat brain, Neurosci. Lett., 164 (1993) 89-92.
58. MacManus, J.P., Hill, I.E., Huang, Z.-G., Rasquinha, I., Xue, D. and Buchan, A.M., DNA damage consistent with apoptosis in transient focal ischaemic neocortex, NeuroReport, 5 (1994) 493-496.
59. Mandybur, T.I. and Chuirazzi, C.C., Astrocytes and the plaques of Alzheimer's disease, Neurology, 40 (1990) 635-639.
60. Martinou, J.-C., Dubois-Dauphin, M., Staple, J.K., Rodriguez, I., Frankowski, H., Missotten, M., Albertini, P., Talabot, D., Catsicas, S., Pietra, C. and Huarte, J., Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia, Neuron, 13 (1994) 1017-1030.
61. Merry, D.E., Veis, D.J., Hickey, W.F. and Korsmeyer, S.J., bcl-2 protein expression is widespread in the developing nervous system and retained in the adult PNS, Development, 120 (1994) 301-311.
62. Middleton, G., Nunez, G. and Davies, A.M., Bax promotes neuronal survival and antagonises the survival effects of neurotrophic factors, Development, 122 (1996) 695-701.
63. Migheli, A., Cavalla, P., Piva, R., Giordana, M.T. and Schiffer, D., bcl-2 protein expression in aged brain and neurodegenerative diseases, NeuroReport, 5 (1994) 1906-1908.
64. Mirra, S.S., Heyman, A., McKeel, D., Sumi, S.M., Grain, B.J., Brownlee, L.M., Vogel, F.S., Hughes, J.P., van Belle, G. and Berg, L., The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease, Neurology, 41 (1991) 479-486.
65. Monaghan, P., Robertson, D., Amos, T.A.S., Dyer, M.J.S., Mason, D.Y. and Greaves, M.F., Ultrastructural localization of BCL-2 protein, J. Histochem. Cytochem., 40 (1992) 1819-1825.
66. Myers, R.H., Vonsattel, J.P., Paskevich, P.A., Kiely, D.K., Stevens, T.J., Cupples L.A., Richardson, E.P. and Bird, E.D., Decreased neuronal and increased oligodendroglial densities in Huntington's disease caudate nucleus, J. Neuropathol. Exp. Neurol., 50 (1991) 729-742.
67. Nishimura, T., Akiyama, H., Yonehara, S., Kondo, H., Ikeda, K., Kato, M., Iseki, E. and Kosaka, K., Fas antigen expression in brains of patients with Alzheimer-type dementia, Brain Res., 695 (1995) 137-145.
68. O'Barr, S., Schultz, J. and Rogers, J., Expression of the protooncogene bcl-2 in Alzheimer's disease brain, Neurobiol. Aging, 17 (1996) 131-136.
69. Oltvai, Z.N. and Korsmeyer, S.J., Checkpoints of duelling dimers foil death wishes, Cell, 79 (1994) 189-192.
70. Oltvai, Z., Milliman, C. and Korsmeyer, S.J., Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death, Cell, 74 (1993) 609-619.
71. Osborn, M. and Weber, K., Biology of disease: tumor diagnosis by intermediate filament typing: a novel tool for surgical pathology, Lab. Invest., 48 (1983) 372-394.
72. Reed, J.C., Bcl-2 and the regulation of programmed cell death, J. Cell Biol., 124 (1994) 1-6.
73. Rosenbaum, D.M., Michaelson, M., Batter, D.K., Doshi, P. and Kessler, J.A., Evidence for hypoxia-induced, programmed cell death of cultured neurons, Ann. Neurol., 36 (1994) 864-870.
74. Satou, T., Cummings, B.J., Cotman, C.W., Immunoreactivity for Bcl-2 protein within neurons in the Alzheimer's disease brain increases with disease severity, Brain Res., 697 (1995) 35-43.
75. Sedlak, T.W., Oltvai, Z.N., Yang, E., Wang, K., Boise, L.H., Thompson, C.B. and Korsmeyer, S.J., Multiple Bcl-2 family members demonstrate selective dimerizations with Bax, Proc. Natl. Acad. Sci. USA, 92 (1995) 7834-7838.
76. Sirimanne, E.S., Guan, J., Williams, C.E. and Gluckman, P.D., Two models for determining the mechanisms of damage and repair after hypoxic-ischaemic injury in the developing rat brain, J. Neurosci. Methods, 55 (1994) 7-14.
77. Smale, G., Nichols, N.R., Brady, D.R., Finch, C.E. and Horton, W.E., Jr., Evidence for apoptotic cell death in Alzheimer's disease, Exp. Neurol., 133 (1995) 225-230.
78. Su, J.H., Anderson, A.J., Cummings, B.J. and Cotman, C.W., Immunohistochemical evidence for apoptosis in Alzheimer's disease, NeuroReport, 5 (1994) 2529-2533.
79. Su, J.H., Satou, T., Anderson, A.J. and Cotman, C.W., Up-regulation of Bcl-2 is associated with neuronal DNA damage in Alzheimer's disease, NeuroReport, 7 (1996) 437-40.
80. Takayama, S., Sato, T., Krajewski, S., Kochel, K., Irie, S., Millan, J.A. and Reed, J.C., Cloning and functional analysis of BAG-1: a novel Bcl-2-binding protein with anti-cell death activity, Cell, 80 (1995) 279-284.
81. Tsujimoto, Y., Cossman, J., Jaffe, E. and Croce, C.M., Involvement of the bcl-2 gene in human follicular lymphoma, Science, 228 (1985) 1440-1443.
82. Tsujimoto, Y. and Croce, C.M., Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma, Proc. Natl. Acad. Sci. USA, 83 (1986) 5214-5218.
83. Van Hoesen, G.W. and Hyman, B.T., Hippocampal formation: anatomy and the patterns of pathology in Alzheimer's disease, Prog. Brain Res., 83 (1990) 445-457.
84. Vonsattel, J.-P., Myers, R.H., Stevens, T.J., Ferrante, R.J., Bird, E.D. and Richardson, E.P., Jr., Neuropathological classification of Huntington's disease, J. Neuropathol. Exp. Neurol., 44 (1985) 559-577.
85. Watt, J.A., Pike, C.J., Walencewicz-Wasserman, A.J. and Cotman, C.W., Ultrastructural analysis of β-amyloid-induced apoptosis in cultured hippocampal neurons, Brain Res., 661 (1994) 147-156.
86. White, E., Life, death and the pursuit of apoptosis, Genes Dev. 10 (1996) 1-15.
87. Wyllie, A.H., Cell death: A new classification separating apoptosis from necrosis. In I.D. Bowen and R.A. Lockshin (Eds.), Cell Death in Biology and Pathology, Chapman and Hall, New York, 1981, pp. 9-34.
88. Wyllie, A.H., Death gets a brake, Nature, 369 (1994) 272-273.
89. Wyllie, A.H., Kerr, J.F.R. and Currie, A.R., Cell death: The significance of apoptosis, Int. Rev. Cytol., 68 (1980) 251-306.
90. Yang, E., Zha, J., Jockel, J., Boise, L.H., Thompson, C.B. and Korsmeyer, S.J., Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death, Cell, 80 (1995) 285-291.
91. Yin, X.M., Oltvai, Z.N. and Korsmeyer, S.J., BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax, Nature, 369 (1994) 321-323.
92. Zhang, P., Hirsch, E.C., Damier, P., Duyckaerts, C. and Javoy-Agid, F., c-fos protein-like immunoreactivity: distribution in the human brain and over-expression in the hippocampus of patients with Alzheimer's disease, Neuroscience, 46 (1992) 9-21.
93. Zhong, L.-T., Sarafian, T., Kane, D.J., Charles, A.C., Mah, S.P., Edwards, R.H. and Bredesen, D.E., bcl-2 inhibits death of central neural cells induced by multiple agents, Proc. Natl. Acad. Sci. USA, 90 (1993) 4533-4537.